Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 340

1.

Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.

Jucaud V, Ravindranath MH, Terasaki PI, Morales-Buenrostro LE, Hiepe F, Rose T, Biesen R.

Clin Exp Immunol. 2016 Mar;183(3):326-40. doi: 10.1111/cei.12724. Epub 2015 Dec 16.

3.

Significance of anti-entactin antibodies in patients with systemic lupus erythematosus and related disorders.

Saxena R, Sturfelt G, Nived O, Wieslander J.

Ann Rheum Dis. 1994 Oct;53(10):659-65.

4.

Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease.

Villalta D, Bizzaro N, Bassi N, Zen M, Gatto M, Ghirardello A, Iaccarino L, Punzi L, Doria A.

PLoS One. 2013 Aug 12;8(8):e71458. doi: 10.1371/journal.pone.0071458. eCollection 2013.

5.

9G4+ autoantibodies are an important source of apoptotic cell reactivity associated with high levels of disease activity in systemic lupus erythematosus.

Jenks SA, Palmer EM, Marin EY, Hartson L, Chida AS, Richardson C, Sanz I.

Arthritis Rheum. 2013 Dec;65(12):3165-75. doi: 10.1002/art.38138.

6.

Circulating group II phospholipase A2 activity and antilipocortin antibodies in systemic lupus erythematosus. Correlative study with disease activity.

Pruzanski W, Goulding NJ, Flower RJ, Gladman DD, Urowitz MB, Goodman PJ, Scott KF, Vadas P.

J Rheumatol. 1994 Feb;21(2):252-7.

PMID:
8182633
7.

Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.

Draborg AH, Lydolph MC, Westergaard M, Olesen Larsen S, Nielsen CT, Duus K, Jacobsen S, Houen G.

PLoS One. 2015 Sep 24;10(9):e0138753. doi: 10.1371/journal.pone.0138753. eCollection 2015. Erratum in: PLoS One. 2016;11(1):e0148151.

8.

Increased frequency of class I and II anti-human leukocyte antigen antibodies in systemic lupus erythematosus and scleroderma and associated factors: a comparative study.

Tozkir H, Pamuk ON, Duymaz J, Gurkan H, Yazar M, Sari G, Tanrikulu H, Pamuk GE.

Int J Rheum Dis. 2016 Dec;19(12):1304-1309. doi: 10.1111/1756-185X.12484. Epub 2014 Oct 8.

PMID:
25292400
9.

Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus.

Li YN, Hu FL, Dai YJ, Li R, Ma XX, Du Y, Feng M, Jia Y, Zhang CF, Zhu L, Ascherman DP, Li ZG.

Lupus. 2014 Aug;23(9):868-75. doi: 10.1177/0961203314530484. Epub 2014 Apr 4.

PMID:
24704774
10.

VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype.

Bhat NM, Lee LM, van Vollenhoven RF, Teng NN, Bieber MM.

J Rheumatol. 2002 Oct;29(10):2114-21.

PMID:
12375320
11.

IgG and IgM autoantibody differences in discoid and systemic lupus patients.

Chong BF, Tseng LC, Lee T, Vasquez R, Li QZ, Zhang S, Karp DR, Olsen NJ, Mohan C.

J Invest Dermatol. 2012 Dec;132(12):2770-9. doi: 10.1038/jid.2012.207. Epub 2012 Jul 5.

12.

A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients.

Pradhan V, Mahant G, Rajadhyaksha A, Surve P, Rajendran V, Patwardhan M, Nadkarni A, Dighe S, Ghosh K.

Rheumatol Int. 2013 May;33(5):1193-9. doi: 10.1007/s00296-012-2519-9. Epub 2012 Sep 13.

PMID:
22971892
13.

Associations of B cell-activating factor (BAFF) and anti-BAFF autoantibodies with disease activity in multi-ethnic Asian systemic lupus erythematosus patients in Singapore.

Howe HS, Thong BYH, Kong KO, Chng HH, Lian TY, Chia FL, Tay KSS, Lau TC, Law WG, Koh ET, Leung BP.

Clin Exp Immunol. 2017 Sep;189(3):298-303. doi: 10.1111/cei.12975. Epub 2017 May 2.

14.

Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus.

O'Neill SG, Giles I, Lambrianides A, Manson J, D'Cruz D, Schrieber L, March LM, Latchman DS, Isenberg DA, Rahman A.

Arthritis Rheum. 2010 Mar;62(3):845-54. doi: 10.1002/art.27286.

15.

Differential immunoglobulin class-mediated responses to components of the U1 small nuclear ribonucleoprotein particle in systemic lupus erythematosus and mixed connective tissue disease.

Mesa A, Somarelli JA, Wu W, Martinez L, Blom MB, Greidinger EL, Herrera RJ.

Lupus. 2013 Nov;22(13):1371-81. doi: 10.1177/0961203313508444.

16.

Increased serum level of prolactin is related to autoantibody production in systemic lupus erythematosus.

Yang J, Li Q, Yang X, Li M.

Lupus. 2016 Apr;25(5):513-9. doi: 10.1177/0961203315622276. Epub 2015 Dec 16.

PMID:
26678441
17.

Reduced IgG anti-small nuclear ribonucleoprotein autoantibody production in systemic lupus erythematosus patients with positive IgM anti-cytomegalovirus antibodies.

Palafox Sánchez CA, Satoh M, Chan EK, Carcamo WC, Muñoz Valle JF, Orozco Barocio G, Oregon Romero E, Navarro Hernández RE, Salazar Páramo M, Cabral Castañeda A, Vázquez Del Mercado M.

Arthritis Res Ther. 2009;11(1):R27. doi: 10.1186/ar2621. Epub 2009 Feb 20.

18.

High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus.

Orjuela A, Suwanichkul A, Canter D, Minard CG, Devaraj S, Hicks MJ, Muscal E, Wenderfer SE.

Am J Nephrol. 2015;41(3):241-7. doi: 10.1159/000381965. Epub 2015 Apr 25.

19.

Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.

Pavón EJ, Zumaquero E, Rosal-Vela A, Khoo KM, Cerezo-Wallis D, García-Rodríguez S, Carrascal M, Abian J, Graeff R, Callejas-Rubio JL, Ortego-Centeno N, Malavasi F, Zubiaur M, Sancho J.

Cytokine. 2013 May;62(2):232-43. doi: 10.1016/j.cyto.2013.02.023. Epub 2013 Mar 26.

PMID:
23538292
20.

Association of Serum Ferritin Levels with Hematological Manifestations in Systemic Lupus Erythematosus Patients from Western India.

Pradhan V, Pandit P, Rajadhyaksha A, Patwardhan M, Surve P, Kamble P, Lecerf M, Bayry J, Kaveri S, Ghosh K, Nadkar MY.

J Assoc Physicians India. 2016 May;64(5):14-18.

PMID:
27735143

Supplemental Content

Support Center